Dr.
Rutledge Ellis-Behnke is a principle investigator in the
Brain and Cognitive Sciences Department at Massachusetts
Institute of Technology and the Department of Anatomy at
the University of Hong Kong Li Ka Shing Faculty of
Medicine. He is also Visiting Professor at Sichuan
University in Chengdu, China. His primary interest is
using nanobiotechnology to reconnect disconnected parts of
the central nervous system (CNS).
He
received his PhD in neuroscience from MIT, BS from Rutgers
University and graduated from Harvard Business School’s
International Senior Manager’s Program (AMP/ISMP).
Prior to returning to school to pursue his PhD, Dr.
Ellis-Behnke held various management positions including
senior vice president of a public company for testing and
consulting services, and co-founder/CEO in 1995 of one of
the first internet companies to do online commerce in
computer memory.
Dr.
Ellis-Behnke is a Fellow and founding board member of the
American Academy of Nanomedicine, Associate Editor of
Neurology for the Journal of Nanomedicine, Scientific
Advisory Board member for the Glaucoma Foundation, member
of the New York Academy of Sciences, China Spinal Cord
Injury Clinical Trial Network, Society for Neuroscience,
Harvard Business School Health Industry Alumni Association
and Sigma Xi.
In
addition to his work in neuroscience and nanomedicine he
introduced the TabletPC to the classroom at MIT and the
University of Hong Kong as part of the migration to the
paperless classroom to deliver all course material and
texts to the students digitally.
|